- Home
- MCHX vs ANIX Comparison
MCHX vs ANIX Comparison
Compare MCHX & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCHX
- ANIX
- Stock Information
- Founded
- MCHX 2003
- ANIX 1982
- Country
- MCHX United States
- ANIX United States
- Employees
- MCHX N/A
- ANIX N/A
- Industry
- MCHX Business Services
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- MCHX Consumer Discretionary
- ANIX Health Care
- Exchange
- MCHX Nasdaq
- ANIX Nasdaq
- Market Cap
- MCHX 79.9M
- ANIX 91.7M
- IPO Year
- MCHX 2004
- ANIX 1987
- Fundamental
- Price
- MCHX $2.10
- ANIX $2.77
- Analyst Decision
- MCHX
- ANIX Strong Buy
- Analyst Count
- MCHX 0
- ANIX 2
- Target Price
- MCHX N/A
- ANIX $8.50
- AVG Volume (30 Days)
- MCHX 107.8K
- ANIX 101.3K
- Earning Date
- MCHX 10-31-2024
- ANIX 01-14-2025
- Dividend Yield
- MCHX N/A
- ANIX N/A
- EPS Growth
- MCHX N/A
- ANIX N/A
- EPS
- MCHX N/A
- ANIX N/A
- Revenue
- MCHX $48,594,000.00
- ANIX N/A
- Revenue This Year
- MCHX N/A
- ANIX N/A
- Revenue Next Year
- MCHX $4.63
- ANIX N/A
- P/E Ratio
- MCHX N/A
- ANIX N/A
- Revenue Growth
- MCHX N/A
- ANIX N/A
- 52 Week Low
- MCHX $1.11
- ANIX $2.15
- 52 Week High
- MCHX $2.40
- ANIX $5.13
- Technical
- Relative Strength Index (RSI)
- MCHX 63.40
- ANIX 33.20
- Support Level
- MCHX $1.98
- ANIX $2.80
- Resistance Level
- MCHX $2.40
- ANIX $3.43
- Average True Range (ATR)
- MCHX 0.15
- ANIX 0.18
- MACD
- MCHX 0.02
- ANIX -0.04
- Stochastic Oscillator
- MCHX 59.23
- ANIX 11.84
About MCHX Marchex Inc. Class B
Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.